MD ANDERSON: Alpha-Stim® Treatment Effective on Common Cancer Symptoms

MINERAL WELLS, Texas, Feb. 27, 2018 /PRNewswire/ -- People battling cancer know that today's treatments are light-years ahead of where they were even a few years ago. But what about the symptoms of the disease, like pain and depression? According to a recent MD Anderson Cancer Center study released this month by the Journal of Pain and Symptom Management, drug-free Alpha-Stim has been found to be an effective treatment for the debilitating pain and overwhelming anxiety and depression that cancer patients often suffer.

There have been scores of studies proving the effectiveness of Alpha-Stim, but this is the most recent one focused on advanced cancer patients – a segment of the population that is routinely prescribed medications for pain, anxiety, insomnia and depression.

The study found that advanced cancer patients who were treated with cranial electrotherapy stimulation (CES) via a handheld, noninvasive medical device called Alpha-Stim for just four weeks saw significant improvement of pain, anxiety, and depression, with insomnia relief trending toward significant.

Daniel L. Kirsch, PhD, inventor of the Alpha-Stim and chairman of Electromedical Products International, Inc. (EPI), noted that one of the most powerful conclusions of the current study is that it asserts the power of Alpha-Stim to go beyond typical prescription medications.

"I am very happy, but not surprised to see that Alpha-Stim technology has been able to help advanced cancer patients on multiple issues during the most difficult period in their lives," Kirsch said. "It has already been recognized as the preferred drug-free choice for a wide variety of people, from veterans fighting pain and depression to dental patients with high anxiety and many others."

While Alpha-Stim is FDA cleared as a fast, safe and proven effective treatment, and has more clinical research than any other device in its class, there have yet to be published studies in patients with advanced cancer. This study examined the safety and efficacy of this non-drug treatment option, affirming years of research that Alpha-Stim is extremely effective, with no serious adverse effects and no risk of addiction, unlike opioids.

Jeffrey Marksberry, MD, chief science and clinical officer at EPI, noted that this study is especially important as Americans struggle with an ongoing opioid epidemic that is fueled by current prescription medications.

"We are very proud and excited about this independent study from MD Anderson. It further corroborates the previous independent studies that found that Alpha-Stim is a viable treatment option for pain, anxiety, insomnia and depression, even in one of the most difficult-to-treat patient populations," Marksberry said. "Not only is it viable, but it is also faster, safer and more effective than pharmaceuticals, without the addictive qualities, and in the long run less expensive."

Click here to read the study from MD Anderson Cancer Center on "Cranial Electrotherapy Stimulation for the Management of Depression, Anxiety, Sleep Disturbance, and Pain in Patients with Advanced Cancer: A preliminary study," published by the Journal of Pain and Symptom Management.

Click here to learn more about Alpha-Stim.

View original content with multimedia:http://www.prnewswire.com/news-releases/md-anderson-alpha-stim-treatment-effective-on-common-cancer-symptoms-300605318.html

SOURCE Electromedical Products International, Inc.